Therapies for Children With Autism Spectrum Disorders

474. Calle-Pascual AL, Vicente A, Martin-Alvarez PJ, et al. Estimation of the prevalence of
diabetes mellitus diagnosed, and incidence of type 1 (insulin-dependent) diabetes mellitus
in the Avila Health Care region of Spain. Diabetes Res Clin Pract. 1993 Jan;19(1):75-81.
X-1, X-4, X-10
475. Cameron MJ, Shapiro RL and Ainsleigh SA. Bicycle Riding: Pedaling Made Possible
through Positive Behavioral Interventions. Journal of Positive Behavior Interventions.
2005;7(3):153-158. X-3, X-4
476. Campbell JM. Statistical comparison of four effect sizes for single-subject designs.
Behav Modif. 2004 Mar;28(2):234-46. X-1, X-2, X-4
477. Campbell M, Adams P, Small AM, et al. Efficacy and safety of fenfluramine in autistic
children. J Am Acad Child Adolesc Psychiatry. 1988 Jul;27(4):434-9. X-10
478. Campbell M, Adams P, Small AM, et al. Naltrexone in infantile autism.
Psychopharmacol Bull. 1988;24(1):135-9. X-10
479. Campbell M, Anderson LT, Deutsch SI, et al. Psychopharmacological treatment of
children with the syndrome of autism. Pediatr Ann. 1984 Apr;13(4):309-13, 316. X-10
480. Campbell M, Anderson LT and Green WH. Behavior-disordered and aggressive children:
new advances in pharmacotherapy. J Dev Behav Pediatr. 1983 Dec;4(4):265-71. X-1, X-
2, X-3, X-4, X-10
481. Campbell M, Anderson LT and Small AM. Pharmacotherapy in autism: A summary of
research at Bellevue/New York University. Brain Dysfunction. 1990 Nov-Dec;3(5-
6):299-307. X-10
482. Campbell M, Anderson LT, Small AM, et al. Naltrexone in autistic children: behavioral
symptoms and attentional learning. J Am Acad Child Adolesc Psychiatry. 1993
Nov;32(6):1283-91. X-10
483. Campbell M, Anderson LT, Small AM, et al. Naltrexone in autistic children: a doubleblind
and placebo-controlled study. Psychopharmacol Bull. 1990;26(1):130-5. X-10
484. Campbell M, Anderson LT, Small AM, et al. The effects of haloperidol on learning and
behavior in autistic children. J Autism Dev Disord. 1982 Jun;12(2):167-75. X-10
485. Campbell M, Armenteros JL, Malone RP, et al. Neuroleptic-related dyskinesias in
autistic children: a prospective, longitudinal study. J Am Acad Child Adolesc Psychiatry.
1997 Jun;36(6):835-43. X-10
486. Campbell M, Cohen IL and Anderson LT. Pharmacotherapy for autistic children: a
summary of research. Can J Psychiatry. 1981 Jun;26(4):265-73. X-1, X-2, X-3, X-10
487. Campbell M, Deutsch SI, Perry R, et al. Short-term efficacy and safety of fenfluramine in
hospitalized preschool-age autistic children: an open study. Psychopharmacol Bull.
1986;22(1):141-7. X-10
488. Campbell M and Harris JC. Resolved: autistic children should have a trial of naltrexone. J
Am Acad Child Adolesc Psychiatry. 1996 Feb;35(2):246-9; discussion 249-51. X-10
D-34